SecBot SecBot

HYPR

Hyperfine, Inc.
Nasdaq· Electromedical & Electrotherapeutic Apparatus· Inc. DE· CIK 0001833769 Healthcare & Medical Devices
$0.7500 +0.03 (+3.73%)
Oct 27 4:00 PM ET · prev $0.7230
Market cap
$76.8M
Micro cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
🔒 Subscribers only
Next earnings
Nov 9
in 12 days · EPS est. −$0.08
1 year
−39.0%
from $1.23 · Oct 28
30 days
−10.3%
from $0.8360
52-week range
$0.7230–1.87
−60% from high · low Oct 26
Avg volume 20D
1.24M
Oct 8 spike 11.06M
Short interest
3.77M
≈3.6% of shares · −3.3%
Days to cover
2.0
at average volume
Insider net
−$91.9K
0 buyers · 2 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read BULLISH 1 report · 90 days
Balance 0 bearish · 1 bullish oldest → newest, height = score
Avg score ·Next Earnings date, Nov 9, 2026
Strongest BULLISH Hyperfine reported record preliminary Q3 2026 revenue of approximately $6.0M, up 53% sequentially from Q2…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBEARISH

    2 insiders sold $91.9K.

  • InstitutionsBULLISH

    Q2 2026: 11 added (0 new), 5 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.090 → −$0.080 over 90 days. 2 up, 0 down in 30 days.

  • Short sellersSTEADY

    Short interest −3.3% to 3.77M shares. 2.0 days to cover, ≈3.6% of shares.

  • TrendDOWNTREND

    9% below its 50-day average. New closing low $0.7230 on Oct 26.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
BlackRock, Inc.DOUBLED4,673,087$6.3M
GEODE CAPITAL MANAGEMENT, LLCDOUBLED1,960,811$2.6M
STATE STREET CORPDOUBLED1,016,970$1.4M
RENAISSANCE TECHNOLOGIES LLCADD945,836$1.3M
NORTHERN TRUST CORPDOUBLED633,054$854.6K
Bank of New York Mellon CorpDOUBLED310,405$419.0K
WELLS FARGO & COMPANY/MNDOUBLED73,992$99.9K
Centiva Capital, LPDOUBLED63,035$85.1K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy3Buy5Hold1Sell0Strong Sell0

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Oct 27, 2026🔒 Fresh data, subscribers only
INITIATE
INITIATE
Sep 22, 2026BTIG
REITERATE
REITERATEBuy
Sep 14, 2026BTIG
REITERATE
REITERATEBuy
Aug 10, 2026B. Riley Securities
REITERATE
REITERATEBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$91.9K
sold · 2 insiders
DateInsiderTypeValue
Aug 24, 2026
HALE BRETT
CFO and CAO
SELL$6.3K
Aug 24, 2026
TEISSEYRE THOMAS
Chief Operating Officer
SELL$6.3K
Jun 3, 2026
Wolterman Dan
Director
AWARD52,600 sh
May 26, 2026
TEISSEYRE THOMAS
Chief Operating Officer
SELL$10.0K
May 26, 2026
HALE BRETT
CFO and CAO
SELL$10.0K
May 22, 2026
ROTHBERG JONATHAN M
Director
AWARD157,700 sh
May 22, 2026
Dahldorf John T
Director
AWARD157,700 sh
May 22, 2026
Wolterman Dan
Director
AWARD157,700 sh

Earnings setup

Estimates
Nov 9
reports in 12 days
−$0.08
EPS estimate, this quarter
+11%
estimate change, 90 days
2↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.08-$0.08–-$0.08+0.0%$5.8M
Next Q-$0.08-$0.08–-$0.08-6.7%$6.6M
Current FY-$0.34-$0.34–-$0.34+1.4%$20.2M
Next FY-$0.32-$0.32–-$0.32+0.0%$26.3M

Short side

FINRA· Oct 15, 2026
3,774,668
shares short
-3.3%
vs prior settlement
2.0
days to cover
≈3.6%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 8, 2026 SEC
Hyperfine reported record preliminary Q3 2026 revenue of approximately $6.0M, up 53% sequentially from Q2 2026, and…
8-K — Impact 6/10
Sep 24, 2026 Listing status
Listing Status: HYPR — Deficient (was Normal)
Hyperfine, Inc. - Class A Common Stock | Nasdaq Financial Status Indicator N → D
Aug 24, 2026 Insider
HALE BRETT sold 7,345 shares
CFO and CAO @ $0.8540 ($6.3K)
Aug 24, 2026 Insider
TEISSEYRE THOMAS sold 7,345 shares
Chief Operating Officer @ $0.8540 ($6.3K)
Jun 30, 2026 Inst.
BlackRock, Inc. — DOUBLED
4,673,087 shares ($6.3M)
Jun 30, 2026 Inst.
GEODE CAPITAL MANAGEMENT, LLC — DOUBLED
1,960,811 shares ($2.6M)
Jun 3, 2026 Insider
Wolterman Dan was granted 52,600 shares
Director
May 22, 2026 SEC
Hyperfine's S-3 shelf registration (File No. 333-295807) became effective on May 21, 2026, enabling the resale of…
EFFECT — Impact 4/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 9, 2026
Earnings date
HYPR Q3 2026 Earnings Scheduled — 2026-11-09
Recent
Sep 24, 2026
Listing
Listing Status: HYPR — Deficient (was Normal)
Hyperfine, Inc. - Class A Common Stock | Nasdaq Financial Status Indicator N → D
Sep 15, 2026
Short interest
Short Interest: HYPR up 16% to 4.2M shares
Settlement 2026-09-15 | Days to cover: 11.25 | ≈4.00% of shares outstanding (est.)
Aug 6, 2026
Earnings date
HYPR Q2 2026 Earnings Scheduled — 2026-08-06
Jul 15, 2026
Short interest
Short Interest: HYPR down 24% to 2.6M shares
Settlement 2026-07-15 | Days to cover: 2.56 | ≈2.59% of shares outstanding (est.)
Jun 30, 2026
Short interest
Short Interest: HYPR up 98% to 3.4M shares
Settlement 2026-06-30 | Days to cover: 1.32 | ≈3.38% of shares outstanding (est.)

SecBot reports

5 filings · 1 bullish · 1 bearish · 3 neutral
All HYPR filing & press-release reports (5)